For men who feel stuck in this cycle, losing weight isnt just about looking betterits about breaking free from the frustration, self-doubt, and mental exhaustion that often accompany weight struggles
Clinical trials of GLP-1 receptor agonists have shown average reductions in daily energy intake of roughly 2030% during early treatment phases , reflecting the combined effects of increased satiety and reduced food preoccupation
You are injecting yourself weekly
Regulates metabolism, aids weight loss
Both are: Highly effective for weight loss Well-tolerated by most people Significantly better than non-medication weight loss approaches Improving health outcomes for millions of patients The small difference in outcomes (7.6% on average) matters less than: Choosing a medication you can take consistently Affording treatment long-term Working with a supportive provider Maintaining lifestyle changes alongside medication Frequently Asked Questions Which is stronger, semaglutide or tirzepatide
Tirzepatide versus semaglutide In the direct head-to-head comparison, the 1-year risk of the primary endpoint including all-cause mortality was 1.3% (95% CI 1.2% to 1.5%) for tirzepatide and 1.3% (95% CI 1.2% to 1.5%) for semaglutide, resulting in a risk difference of 0.0% (95% CI 0.2% to 0.2%) and an HR of 1.06 (95% CI 0.95 to 1.18) (Fig
